A previous study reported an increased level of Lin-ICOS+IL-9+ILC2s in patients with RA who were in clinical remission and that the levels of ILC2s were particularly low in those who had persistent inflammatory disease activity [19]. The gene discussed is IL9; the disease is rheumatoid arthritis.